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Abstract
Since the publication of the human reference genome, the identities of specific genes associated
with human diseases are being discovered at an enormous rate. A central problem is that the
biological activity of these genes is often unclear. Detailed investigations in vertebrate model
organisms, typically mice, have been essential for understanding the activities of many
orthologues of these disease-associated genes. Although gene-targeting approaches1-3 and
phenotype analysis have led to a detailed understanding of nearly 6,000 protein-coding genes3,4,
this number falls significantly short of all >22,000 mouse protein-coding genes5. Similarly, in
zebrafish genetics, one-by-one gene studies using positional cloning6, insertional mutagenesis7-9,
antisense morpholino oligonucleotides10, targeted re-sequencing11-13 and zinc finger and TAL
endonucleases14-17 have made significant contributions to our understanding of the biological
activity of vertebrate genes, but the number of genes studied again falls well short of the >26,000
zebrafish protein-coding genes18. Importantly, for both mice and zebrafish, none of these
strategies is particularly suited to the rapid generation of knockouts in thousands of genes and the
assessment of their biological activity. Enabled by a well-annotated zebrafish reference genome
sequence18,19, high-throughput sequencing and efficient chemical mutagenesis, we describe an
active project that aims to identify and phenotype disruptive mutations in every zebrafish protein-
coding gene. Thus far we have identified potentially disruptive mutations in more than 38% of all
known protein coding genes. We have developed a multi-allelic phenotyping scheme to efficiently
assess the effects of each allele during embryogenesis and have analysed the phenotypic
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consequences of over 1000 alleles. All mutant alleles and data are available to the community and
our phenotyping scheme is adaptable to phenotypic analysis beyond embryogenesis.
Over the past nine years we have been establishing methods for the systematic identification
of disruptive mutations in zebrafish. Given the lack of complete annotation at early stages of
the project we originally employed a reverse genetic approach known as TILLING to
identify mutations in specific genes by sequencing PCR-amplified exons from thousands of
N-ethyl-N-nitrosourea (ENU) mutagenised individuals11-13,20. With the advent of high-
throughput sequencing methods we were able to significantly increase the throughput of this
approach but never reached genome-wide coverage of exons11.
With the release of the Zv8 and Zv9 assemblies of the zebrafish genome and their protein
annotations, we were able to design reagents to extract the annotated exons from zebrafish
genomic DNA, enriching for ~60 Mbp of exome sequence and covering all 26,206 protein-
coding genes18,19 (Fig. 1). By sequencing the exon-enriched DNA from mutagenised F1
individuals we identify ENU induced mutations using a modified version of the 1000
Genomes project variant calling pipeline21,22. We increased throughput by pre-capture
pooling up to eight bar-coded F1 genomic libraries and combining the exon-enriched DNA
into a single high-throughput sequencing sample while retaining adequate sequencing
coverage and depth to identify heterozygous induced mutations (Supplementary Table 1).
For each F1 we now predict protein-coding consequences of the induced mutations and for
each nonsense and essential splice-site mutation we generate a single nucleotide
polymorphism (SNP) genotyping assay11 to facilitate the identification of each mutation in
subsequent generations. We are able to confirm 95% of candidate mutations in subsequent
generations.
We have analysed the exome sequences of 1673 mutagenised F1 individuals and identified
12,002 induced nonsense and 5337 induced essential splice mutations in 10,043 genes. For
4105 genes we have identified two or more disruptive alleles (Supplementary Table 2). With
this set of data we can make predictions about the number of F1 individuals we will need to
analyse to obtain disruptive mutations in each protein-coding gene. The detection of
nonsense and essential splice mutations in new genes gradually decreased over the 1673
sequenced individuals (Fig. 2a), such that the ratio of mutations in new genes to alleles was
1 for the first ten sequenced exomes, but 0.37 for the last ten exomes. On average, each
individual contained 125 nonsense and 168 essential splice mutations, which were common
to the strains used, and among induced mutations were 7 nonsense, 3 essential splice and 90
non-synonymous mutations (Supplementary Table 3). As the number of induced non-
synonymous mutations within each individual was ~10X the sum of nonsense and essential
splice mutations (Fig. 2b), the rate of detecting non-synonymous mutations in new genes
decreased more rapidly over the 1673 exomes, with the ratio of non-synonymous mutations
in new genes to alleles being 0.024 for the last ten exomes. Sequencing 808 individuals
resulted in the identification of 85,338 non-synonymous alleles, corresponding to mutations
in 75% of all known protein-coding genes. We predict that we will identify at least one
disruptive mutation in 75% of protein-coding genes by sequencing ~8000 F1 individuals.
To yield the most value from this resource it is important to identify any phenotypic
consequence of homozygous mutations. Thus we have established a high-throughput,
systematic phenotypic analysis of alleles to assess the developmental consequences of any
given mutation. We have focussed our efforts on induced nonsense and essential splice
mutations. In a two-step, multi-allelic, phenotyping approach, we first identify those
mutations that do not cause a phenotype in the F3 embryos at 5 days post fertilisation (dpf)
(Fig. 3) resulting from crosses of up to 12 pairs of F2s (Fig. 3b). We genotype
phenotypically normal 5 dpf F3 embryos for all mutations identified as heterozygous in both
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F2 parents (Fig. 3c). Homozygous mutations present in the expected Mendelian ratios
among F3 embryos are documented as not causing a phenotype at 5 dpf. Homozygous
mutations present in less than 25% of phenotypically normal embryos are suspected to cause
a phenotype (Fig. 3c).
In the second step of analysis, we test for correlations between the predicted disruptive
mutations and morphological phenotypes (Fig. 3d-e). We re-cross the F2 adults that are
heterozygous for the suspected causal mutation and examine the F3 embryos for all
morphological and behavioural phenotypes during the first 5 dpf. All phenotypes are
genotyped for the given mutation and if over 90% of embryos, for a given phenotype, are
homozygous for the specific mutation it is documented as likely to be causal (Fig. 3d-e),
with 10% tolerance for pipetting and genotyping errors. If less than 90% of embryos with
one phenotype are homozygous for the mutation of interest, it is documented as being linked
to a phenotype rather than causative.
We have performed a phenotypic analysis of 1216 nonsense and essential splice mutations.
Of these, 48 mutations caused a phenotype within the first 5 dpf and 77 alleles were linked
to a phenotype. Among the predicted disruptive mutations, 1065 were deemed to have no
phenotype at 5 dpf and 26 are under further investigation. For all phenotype-genotype
correlations we annotated each of the phenotypic traits using developmental stage,
anatomical entity and phenotypic quality terms to enable phenotype data mining.
This mutation discovery and multi-allelic phenotyping pipeline systematically annotates
zebrafish gene function. Importantly, the described genotype and phenotype correlations do
not constitute proof of causality for the individual allele. Detailed aetiology of a phenotype-
genotype correlation can only be proven by more exhaustive investigation, such as a
complementation test. By combining two distinct potentially disruptive mutations in the
same gene using a compound cross of two independent heterozygous carriers and a genotype
analysis of the expected single-phenotype F3 embryos we can rule out linked mutations
independently associated with each allele. Where a phenotype and allele have been
associated and additional alleles in the same gene are available we perform
complementation crosses to prove causality (Fig. 4).
We find about 6% (74/1216) of alleles are phenotypic, which is low by comparison to
measurements of mouse embryonic lethality23. There are several possible explanations.
Firstly, the alleles generated and analysed in this project are random point mutations across
the length of each gene. Therefore a proportion of alleles do not or only partially disrupt
protein function. However, the position of a mutation is not necessarily a good predictor for
the severity of disruption as is demonstrated by the alleles described in Figure 4 d, h, k.
Secondly, our phenotyping assays include only those morphological and behavioural
changes detectable during the first 5 dpf in live embryos. Subtle phenotypes that require
further intervention, such as immunohistochemistry, are not currently assayed. Finally, the
teleost-specific genome duplication might cause paralogue redundancy. While this is
possible there are few examples of paralogues being completely redundant. In contrast, there
are numerous paralogue pairs where gene expression domains and functions have split
between paralogues24,25. For example, mutants in ttna (Fig. 4 i-k) show a phenotype distinct
from the published ttnb mutant runzel 26.
It is unlikely that a comprehensive functional understanding of all human protein-coding
genes will become available in the near future. Therefore, by providing a systematic analysis
of zebrafish gene function, with phenotypes annotated in searchable, ontology-based
datasets, the reagents described here will advance our knowledge of the biological basis for
human disease. So far we have identified mutations in the orthologues of 3188 of the 5494
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genes currently associated with human disease in GWAS studies (www.genome.gov/
gwastudies) and have at least one allele in 2505 of the 4204 genes associated with a human
phenotype in OMIM (www.omim.org).
Our analysis will provide a rich resource for developmental biologists and clinicians to
facilitate the identification of candidate genes for idiopathic inherited diseases or pathogen
susceptibility. Furthermore, the alleles and data generated by this project are available to the
scientific community through our website (www.sanger.ac.uk/Projects/D_rerio/zmp) and
alleles will be available from two international stock centres, the Zebrafish International
Resource Center (ZIRC) (www.zebrafish.org/zirc) and the European Zebrafish Resource
Center (EZRC) (www.itg.kit.edu/ezrc). Information on how to use these facilities can be
found in the supplementary information. We believe the work described here will
significantly enhance the use of zebrafish as a model organism to study development and
human disease.
Methods
Exome sequencing and SNP calling
Adult male zebrafish were mutagenised using ENU according to improved mutagenesis
protocols11. G0 mutagenised individuals were outcrossed to create large F1 mutagenised
libraries. DNA was isolated from F1 individuals by incubating fin biopsies in 400 ͮl of 100
ͮg/ml proteinase K for 10 h at 55°C, followed by 15 min at 85°C to heat inactivate the
proteinase K. DNA was precipitated by adding 400 ͮl of isopropanol and centrifuging for
30 min at 4000 rpm and 4°C. DNA pellets were washed twice with 400 ͮl of 70% ethanol
followed by centrifugation at 4000 rpm for 5 min, and resuspended in ddH20. DNA from
each individual (1-2 ͮg) was sheared and used to construct 150-200 bp insert Illumina
libraries according to the manufacturers standard protocols.
For the rapid identification of ENU-induced mutations in individual zebrafish covering all
annotated zebrafish protein-coding genes, we developed a whole exome enrichment reagent
using Agilent SureSelect. Oligonucleotides (120mers) were designed at 2X tiling across the
predicted exon coordinates and then manufactured as biotinylated RNA baits and blended
into one tube ready for enrichment. Following completion of a pilot experiment to evaluate
the technology, we developed an exome design using the Ensembl 61 (Zv9) gene set, which
included a total of 60 Mbp of coding sequence and 26,206 genes18,19.
For each F1 genomic Illumina library, 500 ng of DNA was hybridised for 24 h to
biotinylated whole exome RNA baits. Hybridised fragments were enriched using
streptavidin-coated beads, RNA was digested, and remaining libraries of fragments were
amplified for 10 cycles using standard Illumina primers with or without indexing barcodes.
The resulting amplified libraries were run on Illumina GAII or HiSeq2000 machines using
GAII, HiSeq2000v2 or HiSeq2000v3 chemistries to perform 54 bp paired-end sequencing.
Initially, each enriched sample was sequenced on an individual lane of an Illumina GAII
machine using 54 bp paired end runs, achieving a mean of 64 million reads per sample
(Supplementary Table 1). Of those reads, 55% mapped to the exome target sequence, with
90% of the target being covered at 4X and 64% covered at 20X. For the identification of
single nucleotide polymorphism (SNP) variants, we required at least 4X coverage, with 20X
coverage providing the number of reads required for reliable mutation detection29. We
subsequently moved to the HiSeq platform, incorporated barcoding into the library making
and performed pre-capture pooling of libraries. These improvements allowed us to sequence
8 exomes on an individual lane, consequently increasing the throughput and lowering costs
(Supplementary Table 1). These results demonstrated that we could efficiently enrich and
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sequence the zebrafish exome at the coverage required for reliable mutation detection in a
cost-effective manner.
We identified ENU-induced mutations within the exome sequences using a modified version
of the 1000 Genomes Project variant calling pipeline21. Paired reads were aligned to the Zv9
reference assembly using BWA and SNPs were called by SAMtools mpileup, QCALL and
the GATK Unified Genotyper. SNPs not called by all three callers were removed from the
analysis, along with any SNP that did not pass a caller’s standard filters. Additionally, SNPs
were removed where the total read depth was less than the number of samples and where the
genotype quality was lower than 100 for GATK and lower than 50 for QCALL and
SAMtools mpileup. Finally, SNPs within 10 bp of an indel (called by both SAMtools
mpileup and Dindel) were removed. Variation consequences were assigned by the Ensembl
Variant Effect Predictor30 using the Ensembl 61 gene set. A SNP was defined as an induced
mutation if present in one to three individuals, as this allowed for founder effects that may
have arisen from the mutagenesis. If the SNP was present in more than three individuals it
was considered to be common to the strain used. Heterozygous calls found in one to three
samples only were deemed to be induced mutations and those with a nonsense consequence
(Sequence Ontology accession SO:0001587) or essential splice consequence (SO
accessions: SO:0001574 and SO:0001575) were used to design KASP assays.
In a pilot run, a sample of six individual exomes, we confirmed all induced mutations that
were called by at least two of the SNP callers by both KASP genotyping and capillary
sequencing to calculate the false positive rate of our analysis (data not shown). These
genotyping results were used to set filtering parameters within our SNP calling pipeline,
such that 85.7% of SNPs that could not be confirmed by KASP genotyping or capillary
sequencing were removed. Information on common SNPs and insertions/deletions were also
collected in order to avoid them when designing genotyping assays.
To estimate the mutation saturation we used missense mutations, which are present at a
tenfold higher rate. As each mutagenised library displayed different rates of mutagenesis the
order that exomes were sequenced was randomised in the analysis.
We reasoned that the induced nonsense and essential splice mutations were more likely to
result in putative loss of function alleles than non-synonymous mutations. Moreover, we did
not include non-synonymous mutations for the phenotypic analysis on the assumption that if
they are truly loss of function alleles, sequencing more individuals will eventually yield a
nonsense or essential splice allele in those genes.
Phenotyping
Zebrafish were maintained in accordance with UK Home Office regulations, UK Animals
(Scientific Procedures) Act 1986, under project licence 80/2192, which was reviewed by
The Wellcome Trust Sanger Institute Ethical Review Committee.
Heterozygous F2 fish were randomly incrossed and upon egg collection F2 adults were fin
clipped and kept as isolated breeding pairs. For each family we aimed to phenotype 12 pairs,
over 3 weeks of breeding. Each clutch of eggs, which was labelled with the breeding pair
ID, was sorted into three 10cm petri dishes of ~50 embryos each. Embryos were incubated
at 28.5°C. Previous mutagenesis screens were used as a reference for the phenotyping 27,28.
Those phenotypes studied were: day 1 – early patterning defects, early arrest, notochord, eye
development, somites, patterning and cell death in the brain; day 2 – cardiac defects,
circulation of the blood, pigment (melanocytes), eye and brain development; day 3 – cardiac
defects, circulation of the blood, pigment (melanocytes), movement and hatching; day 4 –
cardiac defects, movement, pigment (melanocytes) and muscle defects; day 5 – behaviour
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(hearing, balance, response to touch), swim bladder, pigment (melanocytes, xanthophores
and iridophores), distribution of pigment, jaw, skull, axis length, body shape, notochord
degeneration, digestive organs (intestinal folds, liver and pancreas), left-right patterning. In
the first round of the phenotyping, all phenotypic embryos were discarded. At 5 dpf, >48
phenotypically wild-type embryos were harvested. Embryos were fixed in 100% methanol
and stored at −20°C until genotyping was initiated. In the second round, F2s that were
heterozygous for a suspected causal mutation were re-crossed. All phenotypes observed in
those clutches of embryos were counted, documented and photographed. Phenotypic
embryos were fixed in 100% methanol and at 5 dpf 48 phenotypically wild-type embryos
were also collected. The first round genotyping results were assessed using a Chi-squared
test with a p-value cut off of <0.05. If the number of homozygous embryos was above the
cut-off (i.e. in the expected 25% ratio), the allele was deemed to not cause a phenotype
within the first 5 dpf. If the number of homozygous embryos was below the cut-off, the
allele was carried forward into the second round of phenotyping. In the second round, we
aimed to genotype 48 embryos for each phenotype, ideally from multiple clutches. An allele
was documented as causing a phenotype if the phenotypic embryos were homozygous for
the allele. We allowed up to 10% of embryos for a given phenotype to not be homozygous,
to account for errors in egg collection. Such alleles were outcrossed for further genotyping
with F4 embryos at a later date. Where possible, alleles were also submitted to
complementation tests.
Genotyping
Embryo DNA was prepared by first removing the embryos from 100% methanol and
individual embryos were placed into wells of a 96-well plate. The well positions of
phenotypic and non-phenotypic embryos were documented. Incubating the plate at 80°C for
15 min evaporates all remaining methanol. DNA was extracted from embryos by incubating
in 25 ͮl of lysis buffer (25 mM NaOH + 0.2 mM EDTA) at 95°C for 30 min. Following
this, a volume of 25 ͮl of neutralisation buffer (40 mM Tris-HCl) was added. Genotyping
was performed using the competitive allele-specific PCR (KASP) genotyping system
(KBioscience). Fin clip and embryo DNA was diluted to a working concentration of
1.25-12.5 ng/ͮl. A volume of 4 ͮl of DNA was pipetted into black 384 well hard shell PCR
plates and dried down at room temperature. When the genotyping was performed, the DNA
was resuspended by adding a 4 ͮl PCR mix, according to the manufacturer’s protocol
(KBioscience). Genotyping PCR results were analysed using a PHERAstar plus (BMG
labtech) and the software KlusterCaller (KBioscience).
Cryopreservation of alleles
Sperm from individual males was collected by abdominal massage into 10 ͮl glass
capillaries. The sperm was expelled into 245 ͮl 10% N,N-dimethylacetamide (DMA) in
BSMIS (75 mM NaCl, 70 mM KCl, 2 mM CaCl2, 1 mM MgSO4, 20 mM Tris pH 8.0) and
mixed briefly by pipetting up and down. Eight aliquots of 35 ͮl each were pipetted directly
into 2 ml cryovials and immediately transferred into a pre-chilled 50 ml Falcon tube on a dry
ice/ ethanol bath. After 30 min the samples were moved into liquid nitrogen for long-term
storage. Storage location, date of collection and sample quality were documented together
with genotyping data for each archived male. Representative sperm samples were tested by
in vitro fertilisation.
For in vitro fertilisation sperm samples were thawed by addition of 500 ͮl 37°C BSMIS to
the frozen specimen. The sperm was then activated by the addition of 500 ͮl 28°C 0.5%
fructose in egg water (0.018% (w/v) synthetic sea salt in RO water) and immediately mixed
with fresh eggs in a 6cm glass Petri dish. Eggs were obtained by squeezing females and used
within a few minutes. Sperm motility and egg quality were monitored and documented.
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After about 50 seconds the glass dish was filled with egg water and eggs were transferred
into a 10 cm plastic Petri dish. Fertility rates were checked after incubating the eggs for a
few hours at 28.5°C.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Exome sequencing
a, ENU-mutagenised G0 males are outcrossed to create a population of F1s. Genomic DNA
is taken from F1s, which are either outcrossed or cryopreserved as sperm samples. b, F1
genomic DNA is then subjected to exome sequencing. Illumina libraries are made and
hybridised to the 120mer biotinylated RNA whole exome baits. Streptavidin coated
magnetic beads capture genomic DNA hybridised to the RNA baits, and all other DNA is
discarded. Exome-enriched DNA fragments are sequenced. Blue represents exonic and red
non-coding genomic DNA.
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Figure 2. Mutation detection
a, The cumulative detection of nonsense and essential splice alleles. As each mutagenised
library displayed different rates of mutagenesis the order that exomes were sequenced was
randomised. b, The detection of non-synonymous mutations. Sequencing 808 exomes
resulted in the identification of 85,338 non-synonymous alleles in 19655 genes
corresponding to 75% of all protein-coding genes.
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Figure 3. Phenotypic analysis of alleles
a, F1 individuals were outcrossed to produce an F2 family. The induced disruptive alleles
for one family are shown. b, F2s were incrossed and genotyped. c, First round,
phenotypically wild-type embryos were collected from each clutch at 5 dpf and genotyped
for the mutations heterozygous in both parents. The number of homozygous mutant F3
embryos was assessed using a Chi-squared test (p-value cut-off <0.05). Mutations
homozygous in less than 25% of embryos were suspected to cause a phenotype. Here, there
were no homozygous embryos in the phenotypically wild-type set for the alleles sa365,
sa371 and sa379. d-e, Second round, phenotypes present within each incross were
genotyped for putative phenotypic mutations. d, slc22a7bsa365 shows pigment phenotype. e,
mphosph10sa371 shows small head and pericardiac oedema phenotype. lamc1sa379 mutants
are shown in Fig. 4 l, n.
Kettleborough et al. Page 11
Nature. Author manuscript; available in PMC 2013 October 25.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 4. Confirmation of causality through complementation crosses
Depicted are four examples, polymerase I polypeptide a (polr1a) (a-d), midasin homologue
(yeast) (mdn1) (e-h), titin a (ttna) (i-k) and laminin subunit gamma-1 (lamc1) (l-n), where
heterozygous carriers of two independent alleles in the same gene were used to generate
compound heterozygote offspring. Where possible incrosses of individual alleles are shown
as well. In all images non-phenotypic siblings are above and phenotypic homozygous
mutant or compound heterozygous embryos below. a-c, At 48 hpf embryos homozygous for
either sa1376, sa2745 or compound heterozygous for sa1376 and sa2745 have small eyes, a
hydrocephalic hindbrain and pericardiac oedema. d, sa2745 disrupts a splice donor site
through a G>A transition at the first intronic nucleotide 3ᓉ of coding nucleotide 985. Allele
sa1376 is a C>T transition producing a premature STOP codon at amino acid (aa) 1487. e-g,
At 96 hpf embryos homozygous for either sa1349, sa6631 or compound heterozygous for
sa1349 and sa6631 have smaller heads with malformed jaws and mild pericardiac oedema.
h, sa1349 and sa6631 produce premature STOP codons at aa 4597 (T>A transversion) and
aa 5333 (G>A transition), respectively. i, j, At 48 hpf embryos homozygous for sa787 or
compound heterozygous for sa787 and sa2492 are growth retarded, paralysed and have
pericardiac oedema. k, Alleles sa787 and sa2492 produce premature STOP codons at aa
24946 (C>T transition) and aa 27471 (C>T transition), respectively. l, m, At 24 hpf embryos
homozygous for sa379 or compound heterozygous for sa379 and m466 are shorter with an
undifferentiated notochord, and brain and eye malformations. n, Allele m466 is a G>A
transition producing a premature STOP codon at aa 13. Allele sa379 disrupts a splice
acceptor site through a G>A transition one nucleotide 5ᓉ of coding nucleotide 975.
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